PHARMA MAR, S.A. from 08/07/2024 to 08/07/2024 08/07/2024 17:37 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 1 July and 5 July 2024. Register number: 29571 08/07/2024 10:33 PHARMA MAR, S.A. On business and financial situation The European Commission revokes the decision by which it initially refused to allow Pharma Mar to market Aplidin for multiple myeloma because of a conflict of interest. Register number: 29559
